Mostrando 10 resultados de: 25
Filtros aplicados
Subtipo de publicación
Other(25)
Publisher
Oxford University Press(4)
WB SAUNDERS CO(3)
Elsevier Doyma(2)
Sociedad Española de Patología Digestiva/Arán Ediciones, SL(2)
Blackwell Publishing(1)
Área temáticas
Enfermedades(24)
Farmacología y terapéutica(12)
Medicina y salud(6)
Ginecología, obstetricia, pediatría, geriatría(4)
Cirugía y especialidades médicas afines(3)
Origen
google(25)
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study …
OtherAbstract: Purpose: biosimilar infliximab (CTP-13) has been recently approved for the treatment of several immuPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleCaroli's disease: Clinical presentation, management and outcome. A series of seven patients.
OtherAbstract:Palabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleAdalimumab for induction of histological remission in moderately to severely active ulcerative colitis
OtherAbstract: Background Histological remission represents a target distinct from endoscopic healing in ulcerativePalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleAdalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience
OtherAbstract: OBJECTIVE: To evaluate effectiveness and safety of adalimumab in CD patients of the Madrid area andPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleFactores pbkp_redictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
OtherAbstract: Objective: to evaluate the efficacy and toxicity of infliximab for the treatment of fistulizing CrohPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleEffectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the Eneida Registry
OtherAbstract: Background The effectiveness of the switch to another anti–tumor necrosis factor (anti-TNF) agent isPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleHealth-related quality of life improves during 1-year of postoperative prophylactic drug therapy after ileocecal intestinal resection in Crohn's disease patients: results of …
OtherAbstract:Palabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleP102 Complex Perianal Crohn's Disease: Influence of the Long-Term Maintenance Treatment with Infliximab on the Fistulae Tracks Assessed through Magnetic Resonance
OtherAbstract: Conclusion: Changes in IBDQ scores were associated with consistent changes in both EQ-5D and SF-6D uPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleP120 Usefulness of the faecal calprotectin for the diagnosis of inflammatory bowel disease in patients with spondylorarthritis and no digestive symptoms
OtherAbstract: Background Faecal calprotectin (FC) is a biomarker of bowel inflammation widely spread in diagnosisPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:googleP400 Incidence and risk factors associated to Crohn’s disease recurrence after total proctocolectomy with definitive ileostomy: A long-term single-centre experience
OtherAbstract: Background Total proctocolectomy with definitive ileostomy (TPC-DI) may be the latest therapeutic opPalabras claves:Autores:Maria Cecibeth Vera SaldarriagaFuentes:google